Stockreport

BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq [Yahoo! Finance]

BioAge Labs, Inc.  (BIOA) 
Last bioage labs, inc. earnings: 8/3 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.bio-amber.com
PDF The drug developer's signature product, Azelaprag, isn't yet on sale, but it is undergoing clinical trials in hopes it will one day be. Most Read from Fast Company W [Read more]